The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125238681 12523868 1 I 20151221 20160704 20160704 PER US-JAZZ-2015-US-022268 JAZZ 0.00 F Y 0.00000 20160704 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125238681 12523868 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID 21196 2.25 G ORAL SOLUTION
125238681 12523868 2 SS XYREM SODIUM OXYBATE 1 Oral DOSE ADJUSTMENTS 21196 ORAL SOLUTION
125238681 12523868 3 SS XYREM SODIUM OXYBATE 1 Oral 3.25 G, FIRST DOSE 21196 3.25 G ORAL SOLUTION
125238681 12523868 4 SS XYREM SODIUM OXYBATE 1 Oral 3.25 G, SECOND DOSE 21196 3.25 G ORAL SOLUTION
125238681 12523868 5 SS XYREM SODIUM OXYBATE 1 Oral 3.5 G, THIRD DOSE 21196 3.5 G ORAL SOLUTION
125238681 12523868 6 C ADDERALL XR AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 Oral 25 MG, BID U 0 25 MG CAPSULE
125238681 12523868 7 C LORATADINE. LORATADINE 1 10 MG, QD U 0 10 MG TABLET
125238681 12523868 8 C Alprozolam ALPRAZOLAM 1 UNK U 0 TABLET
125238681 12523868 9 C GABAPENTIN. GABAPENTIN 1 Oral 800 MG, QD U 0 800 MG TABLET
125238681 12523868 10 C LEVOTHYROXINE. LEVOTHYROXINE 1 125 ?G, QD U 0 125 UG TABLET
125238681 12523868 11 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 UNK U 0
125238681 12523868 12 C DIAZEPAM. DIAZEPAM 1 UNK U 0
125238681 12523868 13 C LEVOXYL LEVOTHYROXINE SODIUM 1 UNK U 0
125238681 12523868 14 C NEURONTIN GABAPENTIN 1 UNK U 0 CAPSULE
125238681 12523868 15 C SEROQUEL XR QUETIAPINE FUMARATE 1 UNK U 0 TABLET
125238681 12523868 16 C XANAX ALPRAZOLAM 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125238681 12523868 1 Narcolepsy
125238681 12523868 6 Product used for unknown indication
125238681 12523868 7 Product used for unknown indication
125238681 12523868 8 Product used for unknown indication
125238681 12523868 9 Anxiety
125238681 12523868 10 Product used for unknown indication
125238681 12523868 11 Product used for unknown indication
125238681 12523868 12 Product used for unknown indication
125238681 12523868 13 Product used for unknown indication
125238681 12523868 14 Product used for unknown indication
125238681 12523868 15 Product used for unknown indication
125238681 12523868 16 Anxiety

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125238681 12523868 Nausea
125238681 12523868 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125238681 12523868 1 200606 200607 0
125238681 12523868 3 201404 0
125238681 12523868 4 201404 0
125238681 12523868 5 201404 0
125238681 12523868 6 20130628 0